Many symptoms related to endometrial cancer may improve within 1 year in women with endometrial cancer, with the exception of those with high-risk disease.
Tucatinib was first approved by the FDA for the treatment of patients with HER2-positive advanced unresectable or metastatic breast cancer in combination with trastuzumab and capecitabine on April 17, 2020.
Bispecific antibodies that engage T cells are an effective treatment modality in relapsed/refractory disease and are an important new treatment for relapsed large B-cell lymphoma.
Buying one for your practice or enhancing the one you have will help you cut costs and boost your financial stability.
Kristin M. Daly, MSN, ANP-BC, AOCNP, highlights the difference between somatic and germline variants.
The state-of-the-art facility represents the organization’s vision of global cancer care
Sharon Kauffman, PhD, RN, CNE, NPD-BC, OCN, provides an in-depth look at pirtobrutinib in a downloadable reference sheet.
The last thing patients want is to be put on hold or interrupted by calls at work.
The rise of social media platforms has helped foster a community for adolescent and young adult patients with cancer.
Kara Morris, MSN, RN, OCN; and Christine Wylie, MSN, RN, OCN, discuss the benefits of oral cryotherapy for patients receiving dose-dense doxorubicin.
Patients with triple-negative breast cancer with an increased TIL count in breast tissue were more likely to have an improved distant recurrence-free survival.
Longer duration of CDK4/6 inhibitor prior to treatment with elacestrant correlated with progression-free survival (PFS) improvements in patients with estrogen receptor (ER)-positive, HER2-negative metastatic breast cancer vs standard-of-care options.
Meredith Cummings BSN, RN, OCN, highlights her research on machine learning and its potential application in optimizing symptom management.
Tebentafusp, the first FDA-approved treatment option for patients with unresectable or metastatic uveal melanoma, may cause mild cytokine release syndrome, an expert explains.
Eric Zack, DNP, RN, ACNP-BC, AOCN, BMTCN, describes disseminated intravascular coagulation and best nursing strategies to mitigate the severity of this condition.
A program evaluated at Michigan State University has shown that meditation helps combat burnout and promote well-being among health care workers, particularly in hospice settings.
As with all patients with cancer, providing care for those with lung cancer involves both physiological and psychological aspects.
Undocumented patients with cancer face additional barriers to care.
La-Urshalar Brock, MSN, FNP-BC, CNM, discusses HER2 status and its implications for patients with breast cancer.
“This is a holistic, functional and integrative approach to your mental well-being. So, you start small, and you build up on that. It is not an overnight fix; it is a slow and steady progress.”
Nursing education should be viewed as a long-course endeavor rather than a sprint.
Alyssa Ridad BSN-RN, OCN; and Amanda McKaig, BSN, RN, OCN, discuss oncology nurse perceptions of medical cannabis.
Understanding various clot characteristics and bleeding risk factors can help providers carefully manage acute venous thromboembolism.
Kellie Zeichner BSN, RN, OCN, explains how her institution created a standardized monitoring procedure for insulinoma care.
Although the CDC has put forth a strong effort to improve its opioid guidelines, many providers still feel that more can be done.
Laurel Sopher was diagnosed with breast cancer while pregnant at 15 weeks. Laurel's son, Alexander, was born in 2000. Laurel also delivered twin boys in 2004.
Chemotherapy education is a puzzle personalized for each patient. Each piece of the puzzle represents a different method of instruction to supplement nurses’ interpersonal teaching.
Breast cancer is the leading cause of cancer deaths among Black women of all ages and is increasing in younger women in the U.S.
Sandra Spoelstra, PhD, RN, of the Michigan State University College of Nursing, outlines the essential and growing role of oncology nurses in helping patients with cancer to manage their oral regimens
When considering the importance of medication adherence, former US Surgeon General C. Everett Koop said it best: “Drugs don’t work in patients who don’t take them.” That was 35 years ago, and the issue remains a major area of concern for clinicians today.